Compare KIDS & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KIDS | LAB |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.4M | 326.2M |
| IPO Year | 2016 | 2008 |
| Metric | KIDS | LAB |
|---|---|---|
| Price | $24.80 | $0.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $24.67 | $1.35 |
| AVG Volume (30 Days) | 200.6K | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | $98,049,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $11.85 | $2.63 |
| P/E Ratio | ★ N/A | $2.88 |
| Revenue Growth | ★ 37.95 | N/A |
| 52 Week Low | $14.42 | $0.70 |
| 52 Week High | $25.24 | $1.72 |
| Indicator | KIDS | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 79.20 | 36.43 |
| Support Level | $15.66 | $0.70 |
| Resistance Level | N/A | $0.94 |
| Average True Range (ATR) | 0.99 | 0.05 |
| MACD | 0.43 | -0.01 |
| Stochastic Oscillator | 92.60 | 0.25 |
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.